The approval of Wegovy represents a turning point for healthcare providers to embrace medical management of obesity to help improve chronic weight management for patients. For more than two decades, Novo Nordisk has led the charge to translate the complex science behind obesity into medicines that can make a difference, all while partnering across industries and sectors to change how obesity is understood, diagnosed and treated, said Doug Langa, executive vice president, North America operations and president of Novo Nordisk Inc
Its about creating a calorie deficit, and semaglutide just makes that part a whole lot easier to manage
Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA
Many patients receive B12 injections weekly or monthly, depending on their energy levels, health goals, and lab results
Labeling the reconstitution date helps track the 28-day shelf life window
10.1007/s00213-017-4649-y 393